schreef:
Also in October 2017, Kiadis Pharma drew down EUR5 million as the second tranche of the debt facility of EUR15 million in total from
Kreos Capital. In connection with this second tranche, the Company issued 42,269 warrants towards Kreos Capital. In the period from 30 September 2017 up to the date of these interim financial statements 227,695 warrants resulting in proceeds of EUR1.
66 million have been exercised.